Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4017 for skin function and wound healing in adults with type 2 diabetes mellitus
ISRCTN74621291Phase 2Completed
- Sponsor
- University of Leeds
- Start
- Apr 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing AZD4017 with Placebo (2 arms). Primary endpoint: Skin 11β-HSD1 activity at day 28. Started Apr 2018; status: completed.
02
Drugs
AZD4017
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ISRCTN74621291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN74621291.